Menopause Hormone Therapy (HRT) in Fullerton, CA

Bioidentical hormones in Fullerton: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Estradiol and micronized progesterone are both bioidentical: their structure matches the hormones the ovaries make. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Fullerton, a physician licensed in California can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

At 17.7 OB-GYNs per 100,000 residents (25 listed in the NPI registry), Fullerton sits near the national 17.8 and about level with California's 16.9; 45% of the cities VevaMD covers have a lower rate. Set against the city's 17,717 women aged 45 to 64, that is one OB-GYN for roughly every 710.

Widen the circle and the count grows: 290 in the city or within 10 miles, 1,386 within 25 miles. For the 9,384,822 people who live within 25 miles, that is 14.8 per 100,000. VevaMD is an online option alongside them: a physician licensed in California reviews your intake from Fullerton without an office visit, and an OB-GYN you already see stays your doctor.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11